Fibrinogen Binding Inhibitor Peptide

CAT:
804-HY-P1507-01
Size:
5 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Fibrinogen Binding Inhibitor Peptide - image 1

Fibrinogen Binding Inhibitor Peptide

  • UNSPSC Description:

    Fibrinogen Binding Inhibitor Peptide is a dodecapeptide (HHLGGAKQAGDV, H12), which is a fibrinogen γ-chain carboxy-terminal sequence (γ400-411). Fibrinogen Binding Inhibitor Peptide is a specific binding site of the ligand for activated glycoprotein (GP) IIb/IIIa.
  • Target Antigen:

    Integrin
  • Type:

    Peptides
  • Related Pathways:

    Cytoskeleton
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Cardiovascular Disease
  • Assay Protocol:

    https://www.medchemexpress.com/Fibrinogen_Binding_Inhibitor_Peptide.html
  • Purity:

    99.63
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)|H2O : 100 mg/mL (ultrasonic)
  • Smiles:

    CC(C)[C@@H](C(O)=O)NC([C@H](CC(O)=O)NC(CNC([C@H](C)NC([C@H](CCC(N)=O)NC([C@H](CCCCN)NC([C@H](C)NC(CNC(CNC([C@H](CC(C)C)NC([C@@H](NC([C@@H](N)CC1=CN=CN1)=O)CC2=CN=CN2)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
  • Molecular Weight:

    1189.28
  • References & Citations:

    [1]Okamura Y, et al. Release abilities of adenosine diphosphate from phospholipid vesicles with different membraneproperties and their hemostatic effects as a platelet substitute. J Control Release. 2010 Dec 20;148(3):373-9.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
  • Clinical Information:

    No Development Reported
  • CAS Number:

    89105-94-2